|
|
Blood, 15 March 2006, Vol. 107, No. 6, pp. 2493-2500.
Prepublished online as a Blood First Edition Paper on November 22, 2005; DOI 10.1182/blood-2005-09-3765.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma
Alexey Ushmorov,
Frank Leithäuser,
Olena Sakk,
Andreas Weinhaüsel,
Sergey W. Popov,
Peter Möller, and
Thomas Wirth
From the Departments of Physiological Chemistry and Pathology, University of Ulm, Germany; and the Division of Molecular Diagnostics, ARC Seibersdorf Research, Seibersdorf, Austria.
Many B-lineage-specific genes are down-regulated in Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL). We investigated the involvement of epigenetic modifications in gene silencing in cHL cell lines and in microdissected primary HRS cells. We assessed the expression and methylation status of CD19, CD20, CD79B, SYK, PU.1, BOB.1/OBF.1, BCMA, and LCK, all of which are typically down-regulated in cHL. We could reactivate gene expression in cHL cell lines with the DNA demethylating agent 5-aza-deoxycytidine (5-aza-dC). Using methylation-specific polymerase chain reaction (MSP), bisulfite genomic sequencing, and digestion with methylation-sensitive endonuclease followed by polymerase chain reaction (PCR), we determined the methylation status of promoter regions of PU.1, BOB.1/OBF.1, CD19, SYK, and CD79B. Down-regulation of transcription typically correlated with hypermethylation. Using bisulfite genomic sequencing we found that in microdissected HRS cells of primary cHL SYK, BOB.1/OBF.1, and CD79B promoters were also hypermethylated. Ectopic expression of both Oct2 and PU.1 in a cHL cell line potentiated endogenous PU.1 and SYK expression after 5-aza-dC treatment. These observations indicate that silencing of the B-cell-specific genes in cHL may be the consequence of a compromised regulatory network where down-regulation of a few master transcription factors results in silencing of numerous genes. (Blood. 2006;107:2493-2500)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Classical Hodgkin lymphoma: an epigenetically determined disease?
- Juan F. García
Blood 2006 107: 2217-2218.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
R. D. Gascoyne
Stem cells in Hodgkin lymphoma?
Blood,
June 4, 2009;
113(23):
5694 - 5694.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Jones, C. D. Gocke, Y. L. Kasamon, C. B. Miller, B. Perkins, J. P. Barber, M. S. Vala, J. M. Gerber, L. L. Gellert, M. Siedner, et al.
Circulating clonotypic B cells in classic Hodgkin lymphoma
Blood,
June 4, 2009;
113(23):
5920 - 5926.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Garaud, C. Le Dantec, S. Jousse-Joulin, C. Hanrotel-Saliou, A. Saraux, R. A. Mageed, P. Youinou, and Y. Renaudineau
IL-6 Modulates CD5 Expression in B Cells from Patients with Lupus by Regulating DNA Methylation
J. Immunol.,
May 1, 2009;
182(9):
5623 - 5632.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Buglio, G. V. Georgakis, S. Hanabuchi, K. Arima, N. M. Khaskhely, Y.-J. Liu, and A. Younes
Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
Blood,
August 15, 2008;
112(4):
1424 - 1433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. F. Skibola, J. D. Curry, and A. Nieters
Genetic susceptibility to lymphoma
Haematologica,
July 1, 2007;
92(7):
960 - 969.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Natkunam, E. D. Hsi, P. Aoun, S. Zhao, P. Elson, B. Pohlman, H. Naushad, M. Bast, R. Levy, and I. S. Lossos
Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival
Blood,
January 1, 2007;
109(1):
298 - 305.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
